Genetic polymorphisms of β2- and β3 -adrenergic receptor genes associated with characteristics of the metabolic syndrome in black South African women

Experimental and Clinical Endocrinology and Diabetes

Volumn 116, Issue 4, 2008, Pages 236-240

  Van Rooyen, J M ^a   Pretorius, P J ^a   Britz, M ^a   Huisman, H W ^a   Schutte, A E ^a   Towers, G W ^a   Olckers, A ^a,b   Schwarz, P E H ^c,d   Malan, N T ^a   Malan, L ^a   Schutte, R ^a  

^a NORTH WEST UNIVERSITY   (South Africa)

^b DNAbiotec (Pty) Ltd   (South Africa)

^c UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^d DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

ADRB genotypes; Adrenoceptors; Black African women; Carbohydrate and lipid metabolism; Metabolic syndrome; Polymorphism

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR; BETA 3 ADRENERGIC RECEPTOR; FATTY ACID; GHRELIN; GLUCOSE; INSULIN; LEPTIN; LIPID;

ADULT; ALLELE; ARTICLE; BLOOD PRESSURE; BODY FAT; BODY MASS; CARBOHYDRATE METABOLISM; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; LIPID METABOLISM; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; OBESITY; PATHOPHYSIOLOGY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECEPTOR GENE; SOUTH AFRICA; WILD TYPE; ADIPOSE TISSUE; BLOOD; BODY WEIGHT; GENETICS; HISTOLOGY; NEGRO;

ADIPOSE TISSUE; ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; BLOOD PRESSURE; BODY MASS INDEX; FATTY ACIDS, NONESTERIFIED; FEMALE; HUMANS; LEPTIN; METABOLIC SYNDROME X; POLYMORPHISM, GENETIC; RECEPTORS, ADRENERGIC, BETA-2; RECEPTORS, ADRENERGIC, BETA-3; THINNESS;

EID: 42649109730     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-992785     Document Type: Article

References (45)

1. Allison DB, Heo M et al. Meta-analysis of the association of the Trp64Arg polymorphism in the beta3 adrenergic receptor with body mass index. Int J Obes Relat Metab Disord 1998; 22 (6): 559-566
2. Arner P, Hoffstedt J. Adrenoceptor genes in human obesity. J Intern Med 1999; 245 (6): 667-672
3. Boileau RA, Lohman TG et al. Exercise and body composition of children and youth. Scand J Sport Sci 1985; 7: 17-27
4. Bornstein SR, Schuppenies A et al. Approaching the shared biology of obesity and depression: the stress axis as the locus of gene-environment interactions. Mol Psychiatry 2006; 11 (10): 892-902
5. Bornstein SR, Wong ML et al. 150 years of Sigmund Freud: What would Freud have said about the obesity epidemic? Mol Psychiatry 2006; 11 (12): 1070-1072
6. Clement K, Vaisse C et al. Genetic variation in the beta 3-adrenergic receptor and an increased capacity to gain weight in patients with morbid obesity. N Engl J Med 1995; 333 (6): 352-354
7. Fisher E, Li Y et al. Preliminary evidence of FABP2 A54T polymorphism associated with reduced risk of type 2 diabetes and obesity in women from a German cohort. Horm Metab Res 2006; 38 (5): 341-345
8. Galletti F, Iacone R et al. Lack of association between polymorphism in the beta2-adrenergic receptor gene, hypertension, and obesity in the Olivetti heart study. Am J Hypertens 2004; 17 (8): 718-720
9. Gonzalez Sanchez JL, Proenza AM et al. The glutamine 27 glutamic acid polymorphism of the beta2-adrenoceptor gene is associated with abdominal obesity and greater risk of impaired glucose tolerance in men but not in women: a population-based study in Spain. Clin Endocrinol (Oxf) 2003; 59 (4): 476-481
10. Gouni-Berthold I, Giannakidou E et al. The K121Q polymorphism of the plasma cell glycoprotein-1 gene is not associated with diabetes mellitus type 2 in German Caucasians. Horm Metab Res 2006; 38 (8): 524-529
11. Ishiyama-Shigemoto S, Yamada K et al. Association of polymorphisms in the beta2-adrenergic receptor gene with obesity, hypertriglyceridaemia, and diabetes mellitus. Diabetologia 1999; 42 (1): 98-101
12. Jost MM, Jost P et al. The beta3-adrenergic agonist CL316.243 inhibits insulin signaling but not glucose uptake in primary human adipocytes. Exp Clin Endocrinol Diabetes 2005; 113 (8): 418-422
13. Kasznicki J, Blasiak J et al. The Trp64Arg beta3-adrenergic receptor amino-acid variant is not associated with overweight and type 2 diabetes mellitus in Polish population. Exp Clin Endocrinol Diabetes 2005; 113 (10): 593-597
14. Kiessling A, Ehrhart-Bornstein M. Transcription factor 7-like 2 (TCFL2) - a novel factor involved in pathogenesis of type 2 diabetes. Comment on: Grant et al., Nature Genetics 2006, Published online 15 January 2006. Horm Metab Res 2006; 38 (2): 137-138
15. Kim SH, Kim DJ et al. Significance of beta2-adrenergic receptor gene polymorphism in obesity and type 2 diabetes mellitus in Korean subjects. Metabolism 2002; 51 (7): 833-837
16. Korenblum W, Barthel A et al. Elevated cortisol levels and increased rates of diabetes and mood symptoms in Soviet Union-born Jewish immigrants to Germany. Mol Psychiatry 2005; 10 (11): 974-975
17. Kruger HS, Venter CS et al. Obesity in African women in the North West Province, South Africa is associated with an increased risk of non-communicable diseases: the THUSA study. Transition and Health during Urbanisation of South Africans. Br J Nutr 2001; 86 (6): 733-740
18. Lamounier-Zepter V, Ehrhart-Bornstein M et al. Metabolic syndrome and the endocrine stress system. Horm Metab Res 2006; 38 (7): 437-441
19. Lange LA, Norris JM et al. Association of adipose tissue deposition and beta-2 adrenergic receptor variants: the IRAS family study. Int J Obes (Lond) 2005; 29 (5): 449-457
20. Large V, Hellstrom L et al. Human beta-2 adrenoceptor gene polymorphisms are highly frequent in obesity and associate with altered adipocyte beta-2 adrenoceptor function. J Clin Invest 1997; 100 (12): 3005-3013
21. Leineweber K, Buscher R et al. Beta-adrenoceptor polymorphisms. Naunyn Schmiedebergs Arch Pharmacol 2004; 369 (1): 1-22
22. Li Y, Fisher E et al. Association between functional FABP2 promoter haplotype and type 2 diabetes. Horm Metab Res 2006; 38 (5): 300-307
23. Lima JJ, Feng H et al. Association analyses of adrenergic receptor polymorphisms with obesity and metabolic alterations. Metabolism 2007; 56 (6): 757-765
24. Malczewska-Malec M, Wybranska I et al. An analysis of the link between polymorphisms of the beta2 and beta3 adrenergic receptor gene and metabolic parameters among Polish Caucasians with familial obesity. Med Sci Monit 2003; 9 (6): CR225-34
25. Matthews DR, Hosker JP et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28 (7): 412-419
26. Meirhaeghe A, Helbecque N et al. Impact of polymorphisms of the human beta2-adrenoceptor gene on obesity in a French population. Int J Obes Relat Metab Disord 2000; 24 (3): 382-387
27. Munakata M, Harada Y et al. Molecular-based haplotype analysis of the beta 2-adrenergic receptor gene (ADRB2) in Japanese asthmatic and non-asthmatic subjects. Allergol Int 2006; 55 (2): 191-198
28. Norton K, Olds T. Anthropometrica. A textbook of body measurement for sports and health courses. Sydney, University of New South Wales Press 1996
29. Olckers A, Towers GW et al. Protective effect against type 2 diabetes mellitus identified within the ACDC gene in a black South African diabetic cohort. Metabolism 2007; 56 (5): 587-592
30. Ongphiphadhanakul B, Rajatanavin R et al. Relation of beta3-adrenergic receptor gene mutation to total body fat but not percent body fat and insulin levels in Thais. Metabolism 1999; 48 (5): 564-567
31. Podolsky RH, Barbeau P et al. Candidate genes and growth curves for adiposity in African- and European-American youth. Int J Obes (Lond) 2007; 31 (10): 1491-1499
32. Reichel A, Schwarz J et al. Depression and anxiety symptoms in diabetic patients on continuous subcutaneous insulin infusion (CSII). Mol Psychiatry 2005; 10 (11): 975-976
33. Rupert JL, Monsalve MV et al. Beta2-adrenergic receptor allele frequencies in the Quechua, a high altitude native population. Ann Hum Genet 2000; 64 (Pt 2): 135-143
34. Santos JL, Perez-Bravo F et al. No evidence for an association between genetic polymorphisms of beta(2)- and beta(3)-adrenergic receptor genes with body mass index in Aymara natives from Chile. Nutrition 2002; 18 (3): 255-258
35. Schutte AE, Kruger HS et al. The emergence of the metabolic syndrome in urban obese African women: The POWIRS-study. S Afr J Sci 2005; 101: 61-67
36. Schwarz PE, Bornstein SR et al. Elevated fasting glucose levels predicts IGT and diabetes also in middle-age subjects. Diabetes Res Clin Pract. 2006
37. Schwarz PE, Govindarajalu S et al. Haplotypes in the promoter region of the ADIPOQ gene are associated with increased diabetes risk in a German Caucasian Population. Horm Metab Res 2006; 38 (7): 447-451
38. Schwarz PE, Schwarz J et al. Diabetes prevention - from physiology to implementation. Horm Metab Res 2006; 38 (7): 460-464
39. Schwarz PE, Schwarz J et al. Development of a diabetes prevention management program for clinical practice. Public Health Rep 2007; 122 (2): 258-263
40. Schwarz PE, Towers GW et al. Hypoadiponectinemia is associated with progression toward type 2 diabetes and genetic variation in the ADI-POQ gene promoter. Diabetes Care 2006; 29 (7): 1645-1650
41. Thamer C, Haap M et al. Beta cell function, insulin resistance and plasma adiponectin concentrations are predictors for the change of postprandial glucose in non-diabetic subjects at risk for type 2 diabetes. Horm Metab Res 2006; 38 (3): 178-182
42. Trajkovski M, Mziaut H et al. Genes of type 2 diabetes in beta cells. Endocrinol Metab Clin North Am 2006; 35 (2): 357-369
43. Wenying Y, Zhaojun Y. Obesity and hypertension as two anthropometric predictors for metabolic syndrome. Horm Metab Res 2006; 38 (7): 469-470
44. Wilk JB, Myers RH et al. Adrenergic receptor polymorphisms associated with resting heart rate: the HyperGEN Study. Ann Hum Genet 2006; 70 (Pt 5): 566-573
45. Yuan X, Yamada K et al. Beta 3-adrenergic receptor gene polymorphism is not a major genetic determinant of obesity and diabetes in Japanese general population. Diabetes Res Clin Pract 1997; 37 (1): 1-7